[go: up one dir, main page]

ZA99454B - Novel dosage form. - Google Patents

Novel dosage form.

Info

Publication number
ZA99454B
ZA99454B ZA9900454A ZA99454A ZA99454B ZA 99454 B ZA99454 B ZA 99454B ZA 9900454 A ZA9900454 A ZA 9900454A ZA 99454 A ZA99454 A ZA 99454A ZA 99454 B ZA99454 B ZA 99454B
Authority
ZA
South Africa
Prior art keywords
dosage form
novel dosage
novel
dosage
Prior art date
Application number
ZA9900454A
Inventor
Peter James Watts
Lisbeth Illum
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of ZA99454B publication Critical patent/ZA99454B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9900454A 1998-01-22 1999-01-21 Novel dosage form. ZA99454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form

Publications (1)

Publication Number Publication Date
ZA99454B true ZA99454B (en) 2000-10-23

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900454A ZA99454B (en) 1998-01-22 1999-01-21 Novel dosage form.

Country Status (9)

Country Link
EP (1) EP1059918A1 (en)
JP (1) JP2002501016A (en)
AR (1) AR014467A1 (en)
AU (1) AU2176099A (en)
CA (1) CA2318257A1 (en)
GB (1) GB9801363D0 (en)
NO (1) NO20003640L (en)
WO (1) WO1999037290A1 (en)
ZA (1) ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
EP2013829A4 (en) 2006-05-02 2010-07-07 Proteus Biomedical Inc Patient customized therapeutic regimens
JP5916277B2 (en) 2006-10-25 2016-05-11 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible control activation identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
CN101686800A (en) 2007-02-01 2010-03-31 普罗秋斯生物医学公司 Ingestible Event Marker System
AU2008216170B2 (en) 2007-02-14 2012-07-26 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
WO2008112577A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
WO2008112578A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a deployable antenna
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
EP2215726B1 (en) 2007-11-27 2018-01-10 Proteus Digital Health, Inc. Transbody communication systems employing communication channels
CA2717862C (en) 2008-03-05 2016-11-22 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
CN102341031A (en) 2009-01-06 2012-02-01 普罗秋斯生物医学公司 Ingestion-related biofeedback and personalized medical therapy method and system
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
BR122013009559A2 (en) 2009-04-28 2019-08-06 Proteus Digital Health, Inc. HIGHLY RELIABLE INGESIBLE EVENT MARKERS AND METHODS FOR USING THEM
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
RU2012143791A (en) * 2010-04-07 2014-05-20 Проутьюс Диджитал Хэлс, Инк. MINIATURE INGESTED DEVICE
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible device with medicinal product
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
RU2014106126A (en) 2011-07-21 2015-08-27 Протеус Диджитал Хелс, Инк. DEVICE, SYSTEM AND METHOD OF MOBILE COMMUNICATION
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
BR112015008434A2 (en) 2012-10-18 2017-07-04 Proteus Digital Health Inc apparatus, system and method for adaptively optimizing power dissipation and broadcasting power at a power source for a communication device
TWI659994B (en) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
WO2014197402A1 (en) 2013-06-04 2014-12-11 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
WO2018018034A1 (en) 2016-07-22 2018-01-25 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
JP2019535377A (en) 2016-10-26 2019-12-12 プロテウス デジタル ヘルス, インコーポレイテッド Method for producing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (en) * 2018-10-16 2021-03-12 丹诺医药(苏州)有限公司 Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (en) * 1987-07-23 1991-10-04 Synthelabo PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

Also Published As

Publication number Publication date
NO20003640D0 (en) 2000-07-14
NO20003640L (en) 2000-09-12
GB9801363D0 (en) 1998-03-18
AU2176099A (en) 1999-08-09
JP2002501016A (en) 2002-01-15
WO1999037290A1 (en) 1999-07-29
AR014467A1 (en) 2001-02-28
EP1059918A1 (en) 2000-12-20
CA2318257A1 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
ZA99454B (en) Novel dosage form.
EG24814A (en) Novel compounds.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
MXPA01013362A (en) ANTI-alphav.
ZA200004956B (en) Vaccine composition.
MXPA02001088A (en) 2 pyrazolin 5 ones.
ZA993345B (en) Nefazodone dosage form.
ZA200202537B (en) Pour-on-formulations.
ZA200000865B (en) Dicarboalkoxy dioxolanes.
ZA200201829B (en) New phenylpiperazines.
ZA991272B (en) Novel thiobenzamides.
ZA996133B (en) Substituted benzamides.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200005510B (en) Pharmaceutical composition.
ZA200108968B (en) New compounds.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA993123B (en) Trisresorcinyltriazines.
ZA992899B (en) Novel compound.
ZA987392B (en) Pharmaceutical composition.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA200006118B (en) Novel composition.
MXPA02000261A (en) Novel aminoindanes.
ZA99890B (en) Pharmaceutical compositions.
ZA200000192B (en) Novel composition.